Biologics Prescriber Helper

Drug: All abatacept adalimumab anifrolumab baricitinib certolizumab pegol etanercept golimumab guselkumab infliximab ixekizumab secukinumab tocilizumab tofacitinib upadacitinib ustekinumab

Brand: All Abrilada Actemra Actemra ACTPen Actemra Subcutaneous Injection Adalicip Amgevita Brenzys Cimzia Cosentyx Enbrel Hadlima Humira Hyrimoz Idacio Inflectra Olumiant Orencia Orencia ClickJect Remicade Remsima SC Renflexis Rinvoq Saphnelo Simponi Stelara Taltz Tremfya Xeljanz Yuflyma

Formulation: All Concentrate for injection 200 mg in 10 mL Concentrate for injection 400 mg in 20 mL Concentrate for injection 80 mg in 4 mL Injection 100 mg in 1 mL single use pre-filled pen Injection 100 mg in 1 mL single use pre-filled syringe Injection 125 mg in 1 mL single dose autoinjector Injection 125 mg in 1 mL single dose pre-filled syringe Injection 150 mg in 1 mL pre-filled pen Injection 162 mg in 0.9 mL single use pre-filled pen Injection 162 mg in 0.9 mL single use pre-filled syringe Injection 20 mg in 0.2 mL pre-filled syringe Injection 20 mg in 0.4 mL pre-filled syringe Injection 200 mg in 1 mL single use pre-filled syringe Injection 40 mg in 0.4 mL pre-filled pen Injection 40 mg in 0.4 mL pre-filled syringe Injection 40 mg in 0.8 mL pre-filled pen Injection 40 mg in 0.8 mL pre-filled syringe Injection 45 mg in 0.5 mL Injection 50 mg in 0.5 mL single use pre-filled pen Injection 50 mg in 0.5 mL single use pre-filled syringe Injection 50 mg in 1 mL single use auto-injector, 4 Injection 80 mg in 1 mL single dose pre-filled pen Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL Injections 50 mg in 1 mL single use pre-filled syringes, 4 Oral solution 1 mg per mL, 240 mL Powder for I.V. infusion 100 mg Powder for I.V. infusion 250 mg Solution concentrate for I.V. infusion 300 mg in 2 mL Solution for injection 120 mg in 1 mL pre-filled pen Solution for injection 120 mg in 1 mL pre-filled syringe Solution for injection 200 mg in 1 mL pre-filled pen Tablet 15 mg Tablet 2 mg Tablet 4 mg Tablet 5 mg

Indication: All ankylosing spondylitis giant cell arteritis juvenile idiopathic arthritis non-radiographic axial spondyloarthritis psoriatic arthritis rheumatoid arthritis systemic lupus erythematosus

Treatment Phase: All Balance of supply (including switching formulation) where the full duration of treatment available under a particular treatment phase was not requested in the preceding prescription Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months) Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months) - in a patient of any weight being administered a subcutaneous form of this biological medicine Balance of supply for Initial treatment, Continuing treatment - subcutaneous form Continuing Treatment - balance of supply Continuing or recommencement of treatment (within 12 months of a treatment break) Continuing treatment Continuing treatment - balance of supply Continuing treatment in a patient weighing at least 30 kg Continuing treatment in a patient weighing less than 30 kg Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form First Continuing treatment First Continuing treatment - balance of supply First continuing treatment First continuing treatment - balance of supply Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply Initial 1 (New patient), Initial 2 (Change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply Initial treatment Initial treatment - Initial 1 (New patient) Initial treatment - Initial 1 (new patient weighing at least 30 kg) Initial treatment - Initial 1 (new patient weighing less than 30 kg) Initial treatment - Initial 1 (new patient) Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply Initial treatment - Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) Initial treatment - Initial 2 (Change or re-commencement of treatment after a break of less than 5 years) Initial treatment - Initial 2 (Change or recommencement of treatment after a break in biological medicine of less than 5 years) Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years) Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months) Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months in a patient weighing at least 30 kg) Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months in a patient weighing less than 30 kg) Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) Initial treatment - Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) Initial treatment - Initial 3 (recommencement of a new treatment cycle after a break of more than 12 months in a patient weighing less than 30 kg) Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months in a patient weighing at least 30 kg) Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months) Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab) Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilzumab after resolution of the critical shortage of tocilizumab) Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made Subsequent continuing treatment Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements

Hospital Type: All Any Private Public

Search Reset